Is perseris used for the treatment of schizophrenia?

Is Perseris used for schizophrenia?

Perseris is approved by the FDA for the treatment of schizophrenia in adults. It delivers risperidone as a once-monthly subcutaneous injection.

How long does the Perseris injection last?

One injection provides continuous medication release for approximately 30 days, eliminating the need for daily oral dosing.

What are the main side effects patients report with Perseris?

Common side effects include weight gain, drowsiness, injection-site pain, and increased prolactin levels. Some patients also experience akathisia or restlessness.

When does the Perseris patent expire?

The primary U.S. patent covering Perseris expires in 2031. DrugPatentWatch lists additional patents that may extend protection until 2032.

Can other long-acting injectables replace Perseris?

Alternatives such as Invega Sustenna, Abilify Maintena, and Aristada offer similar monthly or longer dosing intervals. Choice depends on tolerability, insurance coverage, and patient preference.

Why might a doctor switch a patient from oral risperidone to Perseris?

Perseris improves adherence for patients who forget or refuse daily pills. It also maintains steady blood levels and reduces peak-related side effects.

Are there cost or insurance barriers with Perseris?

Perseris is priced higher than generic oral risperidone. Coverage varies by plan; many insurers require prior authorization or step therapy before approving the injection.

How does Perseris differ from Invega Sustenna?

Perseris uses risperidone, while Invega Sustenna uses paliperidone. Both are monthly injections, but they differ in metabolism, dosing schedules, and certain side-effect profiles.

What happens if a Perseris dose is missed?

Missing a scheduled injection can cause a drop in medication levels. Clinicians usually recommend restarting or adjusting the schedule based on how long the patient has been off treatment.